“Integrated Safety and Efficacy Analysis of FMX103 1.5% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea: Results From Two Phase 3 Studies”. 2020. SKIN The Journal of Cutaneous Medicine 4 (5): s55. https://doi.org/10.25251/skin.4.supp.54.